Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
9.59
-0.14 (-1.44%)
Dec 20, 2024, 4:00 PM EST - Market closed
Theravance Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -49.4 | -55.19 | 872.13 | -199.43 | -278.02 | -236.46 | Upgrade
|
| Depreciation & Amortization | 4.57 | 4.26 | 7.02 | 8.6 | 6.97 | 6.21 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.13 | 1.35 | -2.72 | 0.04 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.24 | - | - | - | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | - | - | -23.15 | Upgrade
|
| Stock-Based Compensation | 21.39 | 25.37 | 39.73 | 62.06 | 62.98 | 60.45 | Upgrade
|
| Other Operating Activities | 4.75 | 5.56 | -960.95 | -67.5 | -16.9 | 0.15 | Upgrade
|
| Change in Accounts Receivable | 0.21 | -0.69 | -2.72 | 1.8 | 6.13 | -11.32 | Upgrade
|
| Change in Accounts Payable | -0.39 | 0.01 | -1.61 | -3.53 | 3.66 | -4.27 | Upgrade
|
| Change in Unearned Revenue | -0.2 | -0.22 | -0.19 | -11.46 | -26.47 | -31.25 | Upgrade
|
| Change in Income Taxes | 7.37 | 1.1 | 63.95 | -0.19 | -8.54 | -3.7 | Upgrade
|
| Change in Other Net Operating Assets | -3.94 | -8.54 | -17.08 | -26.17 | -12.56 | 5.14 | Upgrade
|
| Operating Cash Flow | -11.49 | -27 | -186.99 | -207.86 | -250.4 | -238.2 | Upgrade
|
| Capital Expenditures | -0.82 | -2.49 | -0.57 | -3.41 | -6.62 | -3.18 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 1.51 | 4.58 | 0.01 | 0.06 | 0.01 | Upgrade
|
| Divestitures | - | - | - | - | - | 5 | Upgrade
|
| Investment in Securities | -3.26 | -31.72 | 54.87 | 127.89 | 17.27 | -84.88 | Upgrade
|
| Other Investing Activities | - | - | 1,095 | - | - | - | Upgrade
|
| Investing Cash Flow | -4.08 | -32.7 | 1,154 | 124.49 | 10.72 | -83.05 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 380 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -631.6 | -10.73 | -235.35 | -2.15 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -631.6 | -10.73 | 144.65 | -2.15 | Upgrade
|
| Issuance of Common Stock | 0.62 | 0.62 | 0.8 | 111.65 | 144.98 | 6.62 | Upgrade
|
| Repurchase of Common Stock | -33.36 | -199.55 | -132.28 | -9.06 | -9.75 | -3.17 | Upgrade
|
| Other Financing Activities | - | - | 4.28 | - | -16.8 | - | Upgrade
|
| Financing Cash Flow | -32.74 | -198.93 | -758.81 | 91.86 | 263.09 | 1.29 | Upgrade
|
| Net Cash Flow | -48.31 | -258.63 | 208.21 | 8.5 | 23.4 | -319.96 | Upgrade
|
| Free Cash Flow | -12.31 | -29.49 | -187.56 | -211.26 | -257.02 | -241.37 | Upgrade
|
| Free Cash Flow Margin | -19.47% | -51.35% | -365.29% | -381.96% | -357.68% | -328.78% | Upgrade
|
| Free Cash Flow Per Share | -0.25 | -0.53 | -2.55 | -3.04 | -4.12 | -4.34 | Upgrade
|
| Cash Interest Paid | - | - | 22.24 | 39.03 | 24.02 | 26.18 | Upgrade
|
| Cash Income Tax Paid | 0.02 | 0.02 | 117.97 | -4.09 | 0.01 | 0.02 | Upgrade
|
| Levered Free Cash Flow | 5.04 | -13.89 | 24 | -115.85 | -170.49 | -148.45 | Upgrade
|
| Unlevered Free Cash Flow | 6.62 | -12.42 | 27.98 | -110.5 | -165.15 | -128.53 | Upgrade
|
| Change in Net Working Capital | -6.15 | 6.25 | -31.24 | 29.23 | 42.46 | 34.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.